• Home
• FAQs
• FOIA
• Contact
• HEAT
• Download Reader
• Twitter
• YouTube

• Switch to the full site
• Home
• Report Fraud
• Search Exclusions
• What's New
• Criminal/Civil Enforcement
• Most Wanted Fugitives
• Podcasts
• Advisory Opinions
• Corporate Integrity Agreements
• Videos
• Careers

• Home
• Reports & Publications
• Office of Audit Services
• Center For Medicare and Medicaid Services
• Report

Audit (A-03-12-00009)

06-19-2012
Virginia Commonwealth University Medical Center Incorrectly Billed Medicare for the Biological Drug Myozyme

See other reports in this series

Executive Summary

Virginia Commonwealth University Medical Center (the Medical Center) incorrectly billed Medicare for 1,700 units of service for Myozyme, rather than Lumizyme, for each of the 2 line items we reviewed. As a result, the Medical Center was overpaid a total of $484,000.

Complete Report

Download the complete report

Adobe® Acrobat® is required to read PDF files.

Let's start by choosing a topic

• Compendium

  Priority recommendations summarized.

• FY 2016 Work Plan

  OIG projects planned for 2016.

• Semiannual Report

  Significant OIG activities in 6-month increments.

• Compliance 101

  Free educational resources.

• Advisory Opinions

  Legal opinions issued by the OIG about the application of its fraud and abuse authorities.

• Child Support Enforcement

  OIG plays a role in pursuing deadbeat parents.

• All Reports and Publications
  • Office of Audit Services
    • Administration on Aging (AoA)
    • Administration for Children and Families (ACF)
    • Centers for Disease Control and Prevention (CDC)
      • Reports on President's Emergency Plan for AIDS Relief (PEPFAR) Funds
    • Centers for Medicare and Medicaid Services (CMS)
    • Food and Drug Administration (FDA)
    • General Departmental
    • Health Resources and Services
      Administration (HRSA)
    • Indian Health Service (IHS)
    • National Institutes of Health (NIH)
    • Federal/State Joint Audit Initiatives
    • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • Office of Evaluation and Inspections
  • Affordable Care Act Reviews
  • Health Care Fraud and Abuse Control Program Report
  • Semiannual Reports to Congress
  • Medicaid Integrity Reports
  • Top Management & Performance Challenges
  • Compendium of Unimplemented Recommendations
  • Strategic Plan
  • Work Plan
  • Portfolio and Other Reports
  • Freedom of Information Act (FOIA)
  • Federal Register Notices
  • Regulatory Authorities
  • OIG Budget
  • Recovery Act Oversight
• Archives
  • Office of Audit Services
    • Administration for Children and Families (ACF)
    • Centers for Disease Control and Prevention (CDC)
    • Centers for Medicare and Medicaid Services (CMS)
    • Food and Drug Administration (FDA)
    • General Departmental
    • Health Resources and Services
      Administration (HRSA)
    • Indian Health Service (IHS)
    • National Institutes of Health (NIH)
    • Federal/State Joint Audit Initiatives
    • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • Office of Evaluation and Inspections
  • Health Care Fraud and Abuse Control Program Report
  • Semiannual Reports to Congress
  • Medicaid Integrity Reports
  • Top Management & Performance Challenges
  • Compendium of Unimplemented Recommendations: Orange Book
  • Compendium of Unimplemented Recommendations: Red Book
  • Work Plan
  • Federal Register Notices
  • Regulatory Authorities
  • OIG Budget
  • Testimony & Speeches
  • Safe Harbor Regulations

Get Email Updates

Stay up to date on the latest OIG news and opinions